Trials / Completed
CompletedNCT00067665
Hypertension in Hemodialysis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
How high blood pressure in hemodialysis patients should be diagnosed and treated using medications or without medications is the purpose of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ultrafiltration | All patients participating in the trial require evaluation of dry-weight at each dialysis visit for evaluation. An initial weight loss of 0.1kg/10 kg body-weight will be prescribed per dialysis. If ultrafiltration is not tolerated based on muscle cramps, need for excessive saline or symptomatic hypotension, the intensity of ultrafiltration will be reduced by 50%. If ultrafiltration is still not tolerated, the weight loss will be further reduced by 50%. If the patient cannot tolerate at least 0.2 kg incremental weight loss per dialysis, the patient will be said to be at goal dry-weight. Thus, by this protocol, all patients must experience symptoms of volume depletion to be at dry weight. |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2003-08-27
- Last updated
- 2011-03-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00067665. Inclusion in this directory is not an endorsement.